Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J I Hoff

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
The New England Journal of Medicine|August 31, 2000
Intrathecal baclofen for the treatment of dystonia in patients with reflex sympathetic dystrophyB J van Hilten, W J van de Beek, J I Hoff, et al.
Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society|July 29, 1998
Ambulatory quantitative assessment of body position, bradykinesia, and hypokinesia in Parkinson's diseaseR J Dunnewold, J I Hoff, H C van Pelt, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 1, 1994
Motor effects of the partial dopamine agonist (-)-3-(3-hydroxyphenyl)-N-n-propylpiperidine (preclamol) in Parkinson's diseaseL V Metman, V H Sethy, J R Roberts, et al.
Nederlands Tijdschrift Voor Geneeskunde|January 24, 2006
[The first patient with the new variant of Creutzfeldt-Jakob's disease in The Netherlands]C Jansen, M P W A Houben, J I Hoff, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|December 22, 1999
Clinimetric issues of screening for responsiveness to intrathecal baclofen in dystoniaJ J van Hilten, J I Hoff, M C Thang, et al.
Archives of Neurology|September 1, 1994
Sleep disruption in Parkinson's disease. Assessment by continuous activity monitoringB van Hilten, J I Hoff, H A Middelkoop, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
The New England Journal of Medicine|August 31, 2000
Intrathecal baclofen for the treatment of dystonia in patients with reflex sympathetic dystrophyB J van Hilten, W J van de Beek, J I Hoff, et al.
Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society|July 29, 1998
Ambulatory quantitative assessment of body position, bradykinesia, and hypokinesia in Parkinson's diseaseR J Dunnewold, J I Hoff, H C van Pelt, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 1, 1994
Motor effects of the partial dopamine agonist (-)-3-(3-hydroxyphenyl)-N-n-propylpiperidine (preclamol) in Parkinson's diseaseL V Metman, V H Sethy, J R Roberts, et al.
Nederlands Tijdschrift Voor Geneeskunde|January 24, 2006
[The first patient with the new variant of Creutzfeldt-Jakob's disease in The Netherlands]C Jansen, M P W A Houben, J I Hoff, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|December 22, 1999
Clinimetric issues of screening for responsiveness to intrathecal baclofen in dystoniaJ J van Hilten, J I Hoff, M C Thang, et al.
Archives of Neurology|September 1, 1994
Sleep disruption in Parkinson's disease. Assessment by continuous activity monitoringB van Hilten, J I Hoff, H A Middelkoop, et al.
Pageof 2